(1)
Rauck, MD, R. L.; Bookbinder, MD, S. A.; Bunker, MD, T. R.; Alftine, MD, C. D.; Ghalie, MD, R.; Negro-Vilar, MD, PhD, A.; de Jong, MD, E.; Gershon, MD, S. A Randomized, Open-Label Study of Once-a-Day AVINZA® (morphine Sulfate Extended-Release Capsules) Versus Twice-a-Day OxyContin® (oxycodone Hydrochloride Controlled-Release Tablets) for Chronic Low Back Pain: The Extension Phase of the ACTION Trial. J of Opioid Management 2006, 2, 325-333.